Anita Yang, Dominic Tecza, Carly Medwin, Mary Chandran. Impact of Clinical Pharmacist Integration on Weight Management and Transplant Eligibility Among Patients With End‐Stage Kidney Disease With Obesity. // JACCP Journal of the American College of Clinical Pharmacy. – 2026. – DOI: 10.1002/jac5.70336. – URL: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70336?af=R
Anita Yang, Dominic Tecza, Carly Medwin, & Mary Chandran (2026). Impact of Clinical Pharmacist Integration on Weight Management and Transplant Eligibility Among Patients With End‐Stage Kidney Disease With Obesity. JACCP Journal of the American College of Clinical Pharmacy. https://doi.org/10.1002/jac5.70336
Anita Yang, et al. “Impact of Clinical Pharmacist Integration on Weight Management and Transplant Eligibility Among Patients With End‐Stage Kidney Disease With Obesity.” JACCP Journal of the American College of Clinical Pharmacy, 2026. doi:10.1002/jac5.70336.
@article{Yang2026,
title = {Impact of Clinical Pharmacist Integration on Weight Management and Transplant Eligibility Among Patients With End‐Stage Kidney Disease With Obesity},
author = {Yang, Anita and Tecza, Dominic and Medwin, Carly and Chandran, Mary},
journal = {JACCP Journal of the American College of Clinical Pharmacy},
year = {2026},
doi = {10.1002/jac5.70336},
url = {https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70336?af=R}
}
npj Breast Cancer, Published online: 18 November 2026; doi:10.1038/s41523-026-01070-4 Real-world rates and sites of recurrence after neoadjuvant chemoimmunotherapy in early-stage triple-negative breast cancer